Avacopan: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Avacopan. Educational only — not medical advice.
Labeled uses
TAVNEOS is indicated as an adjunctive treatment of adult patients with severe active anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (granulomatosis with polyangiitis [GPA] and microscopic polyangiitis [MPA]) in combination with standard therapy including glucocorticoids. TAVNEOS does not eliminate glucocorticoid use.
Source: FDA labeling via NIH DailyMed (set c93cbc0b…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.